Alkermes

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Alkermes and other ETFs, options, and stocks.

About ALKS

Alkermes Plc is a global biopharmaceutical company, which engages in the business of developing, manufacturing, and commercializing medicines designed to address unmet medical needs of patients in major therapeutic areas such as alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurological disorders and cancer. Its proprietary products include ARISTADA, ARISTADA INITIO, LYBALVI, and VIVITROL. 

CEO
Richard F. Pops
CEORichard F. Pops
Employees
1,800
Employees1,800
Headquarters
Dublin, Dublin
HeadquartersDublin, Dublin
Founded
2011
Founded2011
Employees
1,800
Employees1,800

ALKS Key Statistics

Market cap
4.47B
Market cap4.47B
Price-Earnings ratio
12.50
Price-Earnings ratio12.50
Dividend yield
Dividend yield
Average volume
2.18M
Average volume2.18M
High today
$27.88
High today$27.88
Low today
$26.86
Low today$26.86
Open price
$27.69
Open price$27.69
Volume
1.70M
Volume1.70M
52 Week high
$36.45
52 Week high$36.45
52 Week low
$22.90
52 Week low$22.90

ALKS News

Simply Wall St 3d
Alkermes plc's Earnings Are Not Doing Enough For Some Investors

Alkermes plc's ( ) price-to-earnings (or "P/E") ratio of 12x might make it look like a buy right now compared to the market in the United States, where around h...

Alkermes plc's Earnings Are Not Doing Enough For Some Investors

Analyst ratings

57%

of 14 ratings
Buy
57.1%
Hold
42.9%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.